A randomized, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER).
Cary D AustinMelissa Gonzalez EdickRonald E FerrandoMargaret SolonMiriam BacaKathryn MeshPeter BraddingGail M GauvreauKaharu SuminoJ Mark FitzGeraldElliot IsraelLief BjermerArnaud BourdinJoseph R ArronDavid F ChoyJulie K OlssonFrancis AbreuMonet HowardKit WongFang CaiKun PengWendy S PutnamCécile T J HolwegJohn G MatthewsMonica KraftPrescott G Woodruffnull nullPublished in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2020)
NCT02099656.